Cure My Disease

Don't miss your cure!

 Log in / Sign up

New immune therapy trial offers hope for lymphoma patients out of options

NCT ID NCT03075696

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing a new immune-boosting drug called glofitamab, given alone or with another drug (obinutuzumab), for people with B-cell non-Hodgkin's lymphoma that has come back or hasn't responded to prior treatments. The main goals are to find a safe and effective dose and to see how well the treatment works at controlling the cancer. It is for patients who have limited standard treatment options available.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-HODGKIN'S LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette

    WITHDRAWN

    Turin, Piedmont, 10126, Italy

  • AUSL della Romagna

    RECRUITING

    Ravenna, Emilia-Romagna, 48121, Italy

  • Allegheny Health Network (Pittsburg PA)

    ACTIVE_NOT_RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • Auckland Cancer Trial Centre

    ACTIVE_NOT_RECRUITING

    Auckland, 1023, New Zealand

  • CHU DE RENNES - CHU Pontchaillou

    RECRUITING

    Rennes, 35033, France

  • CHU Saint Eloi

    RECRUITING

    Montpellier, 34295, France

  • Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie

    WITHDRAWN

    Warsaw, 02-781, Poland

  • Ch Lyon Sud

    RECRUITING

    Pierre-Bénite, 69495, France

  • China Medical University Hospital

    ACTIVE_NOT_RECRUITING

    Taichung, 404, Taiwan

  • Cliniques Universitaires St-Luc

    RECRUITING

    Brussels, 1200, Belgium

  • Fond. IRCCS Istituto Nazionale Tumori

    RECRUITING

    Milan, Lombardy, 20133, Italy

  • Helsinki University Central Hospital

    RECRUITING

    Helsinki, 00029, Finland

  • Hopital Claude Huriez

    RECRUITING

    Lille, 59037, France

  • Hopital Henri Mondor

    RECRUITING

    Créteil, 94010, France

  • Hospital Duran i Reynals L'Hospitalet

    ACTIVE_NOT_RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

  • Hospital Univ. 12 de Octubre

    ACTIVE_NOT_RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitari Germans Trias i Pujol

    ACTIVE_NOT_RECRUITING

    Badalona, Barcelona, 08915, Spain

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario Marques de Valdecilla

    ACTIVE_NOT_RECRUITING

    Santander, Cantabria, 39008, Spain

  • Hospital del Mar

    ACTIVE_NOT_RECRUITING

    Barcelona, 08003, Spain

  • Hunstman Cancer Institute

    WITHDRAWN

    Salt Lake City, Utah, 84112, United States

  • Ingalls Memorial Hospital

    WITHDRAWN

    Harvey, Illinois, 60426, United States

  • Istituto Clinico Humanitas

    ACTIVE_NOT_RECRUITING

    Rozzano, Lombardy, 20089, Italy

  • MSKCC

    COMPLETED

    New York, New York, 10065, United States

  • Mount Sinai Medical Center

    ACTIVE_NOT_RECRUITING

    New York, New York, 10029, United States

  • National Taiwan Universtiy Hospital

    ACTIVE_NOT_RECRUITING

    Taipei, 100, Taiwan

  • Peter Maccallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Prince of Wales Hospital

    ACTIVE_NOT_RECRUITING

    Randwick, New South Wales, 2031, Australia

  • Princess Margaret Cancer Center

    ACTIVE_NOT_RECRUITING

    Toronto, Ontario, M5G 1Z5, Canada

  • Rigshospitalet

    RECRUITING

    København Ø, 2100, Denmark

  • Swedish Cancer Inst.

    ACTIVE_NOT_RECRUITING

    Seattle, Washington, 98104, United States

  • UZ Gent

    RECRUITING

    Ghent, 9000, Belgium

  • University of Michigan

    ACTIVE_NOT_RECRUITING

    Ann Arbor, Michigan, 48109-0934, United States

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

    ACTIVE_NOT_RECRUITING

    Wroc?aw, 50-367, Poland

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    RECRUITING

    Późna, 60-569, Poland

  • Uniwersyteckie Centrum Kliniczne

    ACTIVE_NOT_RECRUITING

    Gda?sk, 80-214, Poland

  • Vseobecna Fakultni Nemocnice v Praze, I. Interni Klinika - Klinika Hematoonkologie VFN a 1. LF UK

    ACTIVE_NOT_RECRUITING

    Prague, 128 08, Czechia

  • Washington University

    RECRUITING

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

NON-HODGKIN'S LYMPHOMA